AMPK is a highly conserved master regulator of multiple metabolic pathways and may have therapeutic importance for treating obesity, non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D) 34-36. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.